The efficacy of tumor debulking surgery is improved by adjuvant immunotherapy using imiquimod and anti-CD40

BACKGROUND: Tumor debulking surgery followed by adjuvant chemotherapy or radiotherapy is a standard treatment for many solid malignancies. Although this approach can be effective, it often has limited success against recurrent or metastatic cancers and new multimodality approaches are needed. Adjuva...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:BMC Cancer
Päätekijät: Khong, Andrea, Cleaver, Amanda L, Fahmi Alatas, Muhammad, Wylie, Ben C, Connor, Theresa, Fisher, Scott A, Broomfield, Steve, Lesterhuis, Willem J, Currie, Andrew J, Lake, Richard A, Robinson, Bruce W
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2014
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4320570/
https://ncbi.nlm.nih.gov/pubmed/25518732
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-969
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia